MARSHALL WACE, LLP - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$1,610,302
+22.8%
155,886
+32.9%
0.00%0.0%
Q1 2023$1,311,056
+378.8%
117,268
+261.0%
0.00%
+200.0%
Q4 2022$273,814
+21.2%
32,481
+111.7%
0.00%
Q2 2022$226,000
-77.7%
15,341
-33.2%
0.00%
-100.0%
Q2 2021$1,014,00022,9680.01%
Other shareholders
PULMONX CORP shareholders Q3 2023
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders